Is Tengion Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Tengion Inc (TNGNQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Tengion Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tengion Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Tengion Inc?

Muslim investors may consider investing in Tengion Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Tengion Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Tengion Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Tengion Inc updated?

The Shariah compliance status of Tengion Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Tengion Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Tengion Inc?

You can check the latest Shariah compliance status of Tengion Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Tengion Inc. Stock Analysis TNGNQ

United States Health Care Nano Cap

Tengion, Inc. is a medicine company, which engages in discovering, developing, manufacturing and commercializing neo-organs and products. The company is headquartered in Winston-Salem, North Carolina and currently employs 25 full-time employees. The company went IPO on 2010-04-09. The Company, by using its Organ Regeneration Platform, it creates neo-organs using patient’s own cells. The Company, based on its clinical and preclinical experience is leveraging its Organ Regeneration Platform to develop Neo-Kidney Augment for patients with advanced chronic kidney disease and Neo-Urinary Conduit for bladder cancer patients who are in need of a urinary diversion. The Company’s product candidates are intended to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.

Financial Metrics & Statements of Tengion Inc (TNGNQ)

FAQ's for Tengion Inc (TNGNQ)

According to Musaffa’s Shariah screening methodology, Tengion Inc (TNGNQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.